Last updated: March 3, 2024
Sponsor: Centre hospitalier de Ville-Evrard, France
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
first injection delay and second injection delay
Clinical Study ID
NCT04784572
10477M-EVADOULIM
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients (Males, Females)
- Over the age of 18
- Hospitalized or outpatient
- Patient affiliated with social security, State Medical Aid (AME)
- With prescription of antipsychotic delay by intramuscular injection
- French language mastered
- Given oral consent to pass the self-assessment scales
Exclusion
Exclusion Criteria:
- Patients on long-term analgesic treatment, daily
- Patients with chronic pain with or without analgesic treatment
- Patient not communicating
- Pregnant woman, parturint and nursing mother
- Person deprived of liberty by judicial or administrative decision
- Minor and person subject to legal protection: guardianship or curatorship
Study Design
Total Participants: 393
Treatment Group(s): 1
Primary Treatment: first injection delay and second injection delay
Phase:
Study Start date:
January 22, 2021
Estimated Completion Date:
December 31, 2024
Connect with a study center
Ch Ville Evrard
Neuilly-sur-Marne, 93330
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.